A therapeutic vaporizer inhalation bag attachment system with an integrated valve is disclosed. The attachment system includes a body having a lumen extending between the two openings of the body, a bag coupling, and a valve positioned within the lumen. A method of using the inhalation bag attachment system is also disclosed.

The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.

The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.

An electrolytic gas suction tool includes: a battery; a control substrate which controls power supply from the battery; a pair of positive and negative electrodes which are electrically conducted to or cut off from a positive electrode and a negative electrode of the battery by the control substrate; an electrolysis tank which is capable of storing water and into a lower part of which the pair of positive and negative electrodes are inserted in the mounted state; and a heater device which is heated to generate nicotine containing steam upon receiving the power supply from the battery by the control substrate.

Apparatus consistent with the present disclosure may be a pipe that includes heat transfer materials that have a thermal conductivity of greater than 50 Watts per meter Kelvin. Heat transfer materials may include one or more solid heat sinks (that are rigidly connected to each other or to a portion of the pipe), Peltier devices, or loose fill of a desired size or shape. Fill included in the pipe may also absorb particulate matter or volatile organic compounds. As a user burns or vaporizes materials at one end of the pipe and sucks heated smoke or vapor into the pipe, that user may inhale cool and clean smoke or vapor. Methods and apparatus consistent with the present disclosure may allow a controller at the pipe to send sensor or consumption data to other electronic devices when a number of milligrams of a substance inhaled by a patient are monitored.

A bed has a mattress. A sensor system is configured to sense at least one physical phenomenon through a sleep session. A controller may include at least one processor and memory, the controller configured to receive, through the sleep session, the sensor data; select, from a plurality of optional algorithms, a selected algorithm based on at least one of the sensor data, user input, and checking a clock, where the optional algorithms include (i) a state-based algorithm and (ii) a schedule-based algorithm; update, through the sleep session, using the selected algorithm, a current sleep state of the sleeper; track the sleep session based on the update of the current sleep state of the sleeper through the sleep session; update, through the sleep session, using the tracking of the sleep session, a target environmental-parameter; and send, through the sleep session, automation instructions to an environmental controller.

Devices and methods for delivering oxygen and other therapeutic gases to a target, such as a tissue, a tissue-engineered construct, and a wound, in a controlled and sustained manner are disclosed.

High flow therapy is used to treat Cheyne-Stokes respiration and other types of periodic respiration disorders by periodic application of high flow therapy, adjustment of high flow therapy flow rates and/or periodic additions of CO2 or O2 into the air flow provided to the patient.

High flow therapy is used to treat Cheyne-Stokes respiration and other types of periodic respiration disorders by periodic application of high flow therapy, adjustment of high flow therapy flow rates and/or periodic additions of CO2 or O2 into the air flow provided to the patient.

Described are methods for providing a pulsed dose of a gaseous drug over a portion of total inspiratory time, where the dose of the gaseous drug is delivered at a concentration of nL of gaseous drug per mL tidal volume.